Pulmonary embolism mortality in the United States, 1979-1998 - An analysis using multiple-cause mortality data

被引:421
作者
Horlander, KR
Mannino, DM
Leeper, KV
机构
[1] Emory Univ, Sch Med, Div Pulm Allergy & Crit Care, Atlanta, GA USA
[2] CDCP, Air Pollut & Resp Hlth Branch, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA USA
[3] Atlanta Vet Adm Med Ctr, Atlanta, GA USA
关键词
D O I
10.1001/archinte.163.14.1711
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pulmonary thromboembolism (PTE) is a common clinical problem that is associated with substantial morbidity and mortality. Estimates of PTE mortality and predictions of PTE trends have varied widely. These estimates play a role in the planning of national health strategies. The analysis of pulmonary embolism mortality trends and comorbidities may elucidate how well we treat and prevent the disease as well as identify additional risk factors. Methods: We analyzed PTE (International Classification of Diseases, Ninth Revision code 415.1) as reported on death certificates in the Multiple-Cause Mortality Files compiled by the National Center for Health Statistics from 1979 to 1998. Results: Of all the 42932973 decedents, 572773 (1.3%) had PTE listed on their death certificates and 194389 of these (33.9%) had PTE as the underlying cause of death. The age-adjusted rate of deaths with PTE decreased from 191 per million in 1979 to 94 per million in 1998 overall, decreasing 56% for men and 46% for women. During the study period, the age-adjusted mortality rates for blacks were consistently 50% higher than those for whites, and those for whites were 50% higher than those for people of other races (Asian, American Indian, etc). Within racial strata, mortality rates were consistently 20% to 30% higher among men than among women. Conditions that were of higher likelihood in persons who died with PTE included thrombophlebitis, fractures, trauma, postoperative complications, certain cancers, and the inflammatory bowel diseases. Conclusions: Mortality with PTE in the United States has decreased during the 20-year period. The mortality rates between men and women and between racial groups vary substantially. These findings may be useful in better directing preventive therapy efforts.
引用
收藏
页码:1711 / 1717
页数:7
相关论文
共 56 条
[1]  
*AM CANC SOC, 1997, CANC FACTS FIG
[2]   A POPULATION-BASED PERSPECTIVE OF THE HOSPITAL INCIDENCE AND CASE-FATALITY RATES OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - THE WORCESTER DVT STUDY [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
PATWARDHAN, NA ;
JOVANOVIC, B ;
FORCIER, A ;
DALEN, JE .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (05) :933-938
[3]  
ANDERSON FA, 1995, CLIN CHEST MED, V16, P235
[4]   CHANGING CLINICAL-PRACTICE - PROSPECTIVE-STUDY OF THE IMPACT OF CONTINUING MEDICAL-EDUCATION AND QUALITY ASSURANCE PROGRAMS ON USE OF PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
FORCIER, A ;
PATWARDHAN, NA .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (06) :669-677
[5]  
BERNSTEIN MJ, 1986, JAMA-J AM MED ASSOC, V256, P744
[6]   THE CLINICAL COURSE OF PULMONARY-EMBOLISM [J].
CARSON, JL ;
KELLEY, MA ;
DUFF, A ;
WEG, JG ;
FULKERSON, WJ ;
PALEVSKY, HI ;
SCHWARTZ, JS ;
THOMPSON, BT ;
POPOVICH, J ;
HOBBINS, TE ;
SPERA, MA ;
ALAVI, A ;
TERRIN, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (19) :1240-1245
[7]  
*CDCP, 2002, NAT HLTH INT SURV SE
[8]  
*CDCP, 2002, STAT DIAB SURV 1999, pCH1
[9]   Prevention of venous thromboembolism [J].
Clagett, GP ;
Anderson, FA ;
Geerts, W ;
Heit, JA ;
Knudson, M ;
Lieberman, JR ;
Merli, GJ ;
Wheeler, HB .
CHEST, 1998, 114 (05) :531S-560S
[10]   A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure [J].
Cohn, JN ;
Tognoni, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1667-1675